Carisma Therapeutics, Inc.(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CARM Carisma Therapeutics, Inc.

交易中 12-09 10:38:00 EST 延时

{"stockData":{"symbol":"CARM","market":"US","secType":"STK","nameCN":"Carisma Therapeutics, Inc.","latestPrice":0.0444,"timestamp":1765294680000,"preClose":0.0492,"halted":0,"volume":116146,"delay":15,"floatShares":31255753,"shares":41845078,"eps":0.191977,"marketStatus":"交易中","change":-0.0048,"latestTime":"12-09 10:38:00 EST 延时","open":0.0492,"high":0.0509,"low":0.044,"amount":5430.3005371399995,"amplitude":0.140244,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.191977,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765314000000},"marketStatusCode":2,"adr":0,"exchange":"PINK","adjPreClose":0.0492,"volumeRatio":1.127749},"requestUrl":"/m/hq/s/CARM","defaultTab":"news","newsList":[{"id":"1141836175","title":"Carisma Therapeutics宣布首席执行官Steven Kelly将于11月15日离职","url":"https://stock-news.laohu8.com/highlight/detail?id=1141836175","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141836175?lang=zh_cn&edition=full","pubTime":"2025-10-16 04:28","pubTimestamp":1760560089,"startTime":"0","endTime":"0","summary":"Carisma Therapeutics宣布，作为清算活动的一部分，首席执行官Steven Kelly将于11月15日离职。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CARM"],"gpt_icon":0},{"id":"1125797846","title":"根据SEC文件显示，Modernatx将向Carisma Therapeutics支付400万美元且无需承担后续财务义务","url":"https://stock-news.laohu8.com/highlight/detail?id=1125797846","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125797846?lang=zh_cn&edition=full","pubTime":"2025-09-18 21:21","pubTimestamp":1758201686,"startTime":"0","endTime":"0","summary":"根据SEC文件披露，Modernatx将向Carisma Therapeutics支付400万美元，并且无需承担任何进一步的财务支付义务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CARM"],"gpt_icon":0},{"id":"2565735559","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大跌9.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565735559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565735559?lang=zh_cn&edition=full","pubTime":"2025-09-04 21:31","pubTimestamp":1756992713,"startTime":"0","endTime":"0","summary":"北京时间2025年09月04日21时31分，Carisma Therapeutics, Inc.股票出现波动，股价快速跳水9.57%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904213153a4b40e58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904213153a4b40e58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4539","CARM"],"gpt_icon":0},{"id":"2558579887","title":"Carisma Therapeutics, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558579887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558579887?lang=zh_cn&edition=full","pubTime":"2025-08-09 01:12","pubTimestamp":1754673123,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日01时12分，Carisma Therapeutics, Inc.股票出现波动，股价急速下跌5.02%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809011203a6db6c9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809011203a6db6c9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","CARM","BK4139","BK4539"],"gpt_icon":0},{"id":"2557543813","title":"这家公司裁员95%公司仅剩6人","url":"https://stock-news.laohu8.com/highlight/detail?id=2557543813","media":"制药界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557543813?lang=zh_cn&edition=full","pubTime":"2025-08-08 14:27","pubTimestamp":1754634434,"startTime":"0","endTime":"0","summary":"Carisma Therapeutics近期宣布了一项重大裁员计划，将公司员工从46人削减至仅6人，占总员工数的约87%。财务状况与运营资金 截至2024年底，Carisma Therapeutics的现金及现金等价物为1790万美元，预计可维持公司运营至2025年下半年。为了减少运营开支，公司决定进行大规模裁员，预计裁员将产生约380万美元的费用，主要用于员工离职福利。公司计划在2025年第一季度为其肝纤维化项目提名一个开发候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808143055a47c924f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808143055a47c924f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139"],"gpt_icon":0},{"id":"2557756792","title":"Carisma Therapeutics, Inc.盘中异动 急速下跌6.29%报0.286美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557756792","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557756792?lang=zh_cn&edition=full","pubTime":"2025-08-07 23:46","pubTimestamp":1754581587,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日23时46分，Carisma Therapeutics, Inc.股票出现波动，股价快速跳水6.29%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807234627a6d929a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807234627a6d929a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","CARM","BK4007"],"gpt_icon":0},{"id":"2550757744","title":"Carisma Therapeutics, Inc.7月8日成交额为26.06万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550757744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550757744?lang=zh_cn&edition=full","pubTime":"2025-07-09 09:26","pubTimestamp":1752024416,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，Carisma Therapeutics, Inc.成交额为26.06万美元，成交额较昨日增加29.71%，当日成交量为65.72万股。Carisma Therapeutics, Inc.于2025年7月8日涨1.77%，报0.402美元，该股过去5个交易日涨2.55%，年初至今跌4.06%，过去60日涨103.03%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709092700a43f0c9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709092700a43f0c9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4007","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2549530567","title":"Carisma Therapeutics, Inc.7月7日成交额为20.09万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549530567?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:26","pubTimestamp":1751937972,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日，Carisma Therapeutics, Inc.成交额为20.09万美元，成交额较昨日增加23.03%，当日成交量为49.53万股。Carisma Therapeutics, Inc.于2025年7月7日跌1.99%，报0.395美元，该股过去5个交易日跌1.5%，年初至今跌5.73%，过去60日涨124.43%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708092623a43ccffa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708092623a43ccffa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","CARM","BK4139","BK4539"],"gpt_icon":0},{"id":"2548832748","title":"Carisma Therapeutics, Inc.7月1日成交额为45.01万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548832748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548832748?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:27","pubTimestamp":1751419625,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Carisma Therapeutics, Inc.成交额为45.01万美元，成交额较昨日减少3.79%，当日成交量为115.27万股。Carisma Therapeutics, Inc.于2025年7月1日涨3.4%，报0.405美元，该股过去5个交易日跌5.4%，年初至今跌3.37%，过去60日涨110.89%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702092709a72962c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702092709a72962c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","BK4539","CARM"],"gpt_icon":0},{"id":"2548042270","title":"Carisma Therapeutics, Inc.6月30日成交额为46.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548042270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548042270?lang=zh_cn&edition=full","pubTime":"2025-07-01 09:25","pubTimestamp":1751333141,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，Carisma Therapeutics, Inc.成交额为46.79万美元，成交额较昨日增加29.51%，当日成交量为118.94万股。Carisma Therapeutics, Inc.于2025年6月30日跌2.25%，报0.392美元，该股过去5个交易日跌13.17%，年初至今跌6.54%，过去60日涨76.4%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701092547a7272ee1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701092547a7272ee1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CARM","BK4539","BK4007"],"gpt_icon":0},{"id":"2545484417","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大跌6.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545484417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545484417?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:43","pubTimestamp":1750686186,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时43分，Carisma Therapeutics, Inc.股票出现异动，股价大幅下跌6.85%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623214306978b575d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623214306978b575d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","CARM","BK4139"],"gpt_icon":0},{"id":"2544178508","title":"Carisma Therapeutics, Inc.盘中异动 股价大涨5.51%报0.530美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544178508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544178508?lang=zh_cn&edition=full","pubTime":"2025-06-20 21:35","pubTimestamp":1750426512,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日21时35分，Carisma Therapeutics, Inc.股票出现异动，股价大幅上涨5.51%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213512a4b4c047&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213512a4b4c047&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2544903936","title":"Carisma Therapeutics, Inc.盘中异动 大幅下挫6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544903936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544903936?lang=zh_cn&edition=full","pubTime":"2025-06-18 21:30","pubTimestamp":1750253457,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日21时30分，Carisma Therapeutics, Inc.股票出现异动，股价大幅跳水6.64%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618213057a7109593&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618213057a7109593&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","BK4007","CARM"],"gpt_icon":0},{"id":"2544198099","title":"Carisma Therapeutics, Inc.6月16日成交额为182.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544198099","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544198099?lang=zh_cn&edition=full","pubTime":"2025-06-17 09:28","pubTimestamp":1750123695,"startTime":"0","endTime":"0","summary":"美东时间2025年6月16日，Carisma Therapeutics, Inc.成交额为182.82万美元，成交额较昨日减少74.75%，当日成交量为409.43万股。Carisma Therapeutics, Inc.于2025年6月16日跌4.85%，报0.43美元，该股过去5个交易日涨89.3%，年初至今涨2.55%，过去60日涨3.29%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617092819a70d306c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617092819a70d306c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","CARM","BK4139","BK4539"],"gpt_icon":1},{"id":"2543651485","title":"Carisma Therapeutics, Inc.6月13日成交额为723.90万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543651485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543651485?lang=zh_cn&edition=full","pubTime":"2025-06-14 09:28","pubTimestamp":1749864483,"startTime":"0","endTime":"0","summary":"美东时间2025年6月13日，Carisma Therapeutics, Inc.成交额为723.90万美元，成交额较昨日增加13.23%，当日成交量为1276.51万股。Carisma Therapeutics, Inc.于2025年6月13日跌17.62%，报0.452美元，该股过去5个交易日涨132.78%，年初至今涨7.78%，过去60日涨7.52%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614092811a7088ba5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614092811a7088ba5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CARM","BK4539","BK4007"],"gpt_icon":1},{"id":"2542540625","title":"Carisma Therapeutics, Inc.6月11日成交额为2355.10万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542540625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542540625?lang=zh_cn&edition=full","pubTime":"2025-06-12 09:27","pubTimestamp":1749691671,"startTime":"0","endTime":"0","summary":"美东时间2025年6月11日，Carisma Therapeutics, Inc.成交额为2355.10万美元，成交额较昨日减少96.10%，当日成交量为3777.01万股。Carisma Therapeutics, Inc.于2025年6月11日跌45.66%，报0.603美元，该股过去5个交易日涨242.73%，年初至今涨43.96%，过去60日涨45.7%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612092757a4a43111&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612092757a4a43111&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CARM","BK4539","BK4007"],"gpt_icon":1},{"id":"2542023317","title":"Carisma Therapeutics, Inc.股价拉升225.35% 市值涨6948.67万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542023317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542023317?lang=zh_cn&edition=full","pubTime":"2025-06-10 21:31","pubTimestamp":1749562279,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日21时31分，Carisma Therapeutics, Inc.股票出现波动，股价急速上涨225.35%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213119a70238a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213119a70238a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CARM","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2518273788","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大跌6.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518273788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518273788?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:33","pubTimestamp":1741613632,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时33分，Carisma Therapeutics, Inc.股票出现异动，股价大幅下跌6.29%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213352a26a2585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213352a26a2585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CARM"],"gpt_icon":0},{"id":"2517161899","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大涨5.00%报0.420美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161899?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:10","pubTimestamp":1741273800,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时10分，Carisma Therapeutics, Inc.股票出现波动，股价大幅拉升5.00%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306231000a2629aa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306231000a2629aa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CARM","BK4139"],"gpt_icon":0},{"id":"2514885637","title":"Carisma Therapeutics, Inc.盘中异动 早盘急速拉升6.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514885637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514885637?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:34","pubTimestamp":1740580499,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时34分，Carisma Therapeutics, Inc.股票出现异动，股价大幅上涨6.93%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223459abddedd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223459abddedd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sesenbio.com","description":"CARISMA Therapeutics Inc.于2008年2月25日在特拉华州法律下成立。该公司是一家临床阶段细胞治疗公司，专注于利用专有的CAR-M细胞治疗平台开发用于治疗癌症和严重疾病的转化免疫疗法。该公司创建了一个全面的细胞治疗平台，使工程化巨噬细胞和单核细胞的治疗用途成为可能，属于白细胞的一个亚群，称为髓细胞。","exchange":"PINK","name":"Carisma Therapeutics, Inc.","nameEN":"Carisma Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Carisma Therapeutics, Inc.(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Carisma Therapeutics, Inc.(CARM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Carisma Therapeutics, Inc.,CARM,Carisma Therapeutics, Inc.股票,Carisma Therapeutics, Inc.股票老虎,Carisma Therapeutics, Inc.股票老虎国际,Carisma Therapeutics, Inc.行情,Carisma Therapeutics, Inc.股票行情,Carisma Therapeutics, Inc.股价,Carisma Therapeutics, Inc.股市,Carisma Therapeutics, Inc.股票价格,Carisma Therapeutics, Inc.股票交易,Carisma Therapeutics, Inc.股票购买,Carisma Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Carisma Therapeutics, Inc.(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Carisma Therapeutics, Inc.(CARM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}